http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114533890-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8fb6ecc92235db07212332e4acd96a6d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6907
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G83-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G83-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
filingDate 2022-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c7c74837db3759ac7574ba740ef960b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7cd2e13b35d47251868610fd58d3832
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdd4d27533310d14117cf78b427e9e2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18ef39b5063201ac0606a21d132898c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e9f1486660da91df699d0e9f5cbfe02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac61905b39ccffc0ffe3c81c39622415
publicationDate 2022-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114533890-A
titleOfInvention A kind of preparation method and product of sorafenib liver cancer targeting micelle
abstract The invention discloses a preparation method and a product of a sorafenib liver cancer targeting micelle, belonging to the technical field of medicine. The preparation method of the sorafenib liver cancer targeting micelles includes the following steps: (1) dissolving mPEG-NH 2 , adding BLG-NCA and Phe-NCA, adding ether after the reaction is completed, and filtering to obtain mPEG-b -P(LP-co-BLG); (2) dissolving mPEG-b-P(LP-co-BLG) obtained in step (1), adding HBr/acetic acid solution, adding ether after the reaction is completed, filtering, and the precipitate is dialyzed (mPEG-b-P(LP-co-LG)) is obtained later; (3) triethylamine is added after dissolving the mPEG-b-P (LP-co-LG) gained in step (2) with folic acid, and after the reaction is completed , and then mixed with sorafenib solution, stirred, and dialyzed to obtain sorafenib liver cancer targeting micelles.
priorityDate 2022-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015283246-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94429
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27638
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21941165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426248706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451203358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487010
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516572
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410697574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453327643
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474833
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14797
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556475
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8058
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487901
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6597
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428288831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70699587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14923
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8019
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25423
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457586576
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606

Total number of triples: 78.